Diagnostic criteria for nephrotic syndrome
Reading File
Searching for diagnostic criteria and clinical features of nephrotic syndrome.
search_medical_text
nephrotic syndrome diagnostic criteria proteinuria hypoalbuminemia edema
Harrison's Principles of Internal Medicine, Twenty First Edition
Page 8392
search_medical_text
nephrotic syndrome causes classification pathophysiology
Harrison's Principles of Internal Medicine, Twenty First Edition
Page 8394
GradeResponse
GradeResponse
Nephrotic Syndrome — Diagnostic Criteria
Core Diagnostic Triad
According to Harrison's Principles of Internal Medicine (21st ed., p. 8392), nephrotic syndrome (NS) is defined by three essential features:
| Feature | Threshold |
|---|---|
| Proteinuria | > 3.5 g/day (heavy, "nephrotic-range") |
| Hypoalbuminemia | Serum albumin < 3.5 g/dL |
| Edema | Peripheral, typically pitting; periorbital in children |
All three must be present for the diagnosis. In clinical practice, proteinuria > 3.5 g/day in adults (or > 40 mg/m²/hr in children) is the sine qua non.
Associated Features (Not Required but Commonly Present)
| Feature | Details |
|---|---|
| Hyperlipidemia | Elevated LDL, reduced HDL (compensatory hepatic lipoprotein synthesis) |
| Lipiduria | Oval fat bodies, fatty casts, Maltese cross appearance under polarized light |
| Hypercoagulability | Loss of antithrombin III, proteins C and S → venous thrombosis risk |
| Hypertension | Especially in secondary causes |
| Frothy urine | Due to heavy proteinuria |
Diagnostic Workup
Urine studies:
- 24-hour urine protein (gold standard) — confirms > 3.5 g/day
- Spot urine protein-to-creatinine ratio > 3.5 mg/mg (practical equivalent)
- Urinalysis: oval fat bodies, fatty/granular casts, Maltese crosses under polarized light
Serum labs:
- Albumin < 3.5 g/dL
- Lipid panel: elevated total cholesterol, LDL, triglycerides
- BMP/CMP: assess renal function (creatinine, BUN, eGFR)
- Complement levels (C3, C4): low in membranoproliferative GN, lupus nephritis
- ANA, anti-dsDNA: if lupus nephritis suspected
- Serum protein electrophoresis (SPEP): if amyloidosis or multiple myeloma considered
- Anti-PLA₂R antibody: 70% of primary membranous nephropathy cases (Harrison's, p. 8394)
- Hepatitis B/C serologies, HIV: secondary causes
Renal biopsy:
- Required in adults to determine the underlying pathologic cause
- May be deferred in children (presumptive minimal change disease treated empirically with steroids)
Causes (Primary vs. Secondary)
Primary (idiopathic) glomerulopathies:
- Minimal Change Disease (MCD) — most common in children
- Focal Segmental Glomerulosclerosis (FSGS)
- Membranous Nephropathy (MN) — most common in adults
- Membranoproliferative GN (MPGN) / C3 glomerulopathy
Secondary causes:
- Diabetes mellitus (diabetic nephropathy)
- Systemic lupus erythematosus (lupus nephritis class V)
- Amyloidosis (AL amyloid, SAA/reactive amyloidosis)
- Infections: Hepatitis B/C, HIV, malaria
- Drugs: NSAIDs, gold, penicillamine, heroin
- Malignancy: solid tumors (MN), hematologic (MCD)
Key Distinctions: Nephrotic vs. Nephritic
| Feature | Nephrotic | Nephritic |
|---|---|---|
| Proteinuria | > 3.5 g/day | < 3.5 g/day |
| Hematuria | Absent or minimal | Prominent (RBC casts) |
| Hypertension | Variable | Common |
| Edema | Prominent | Moderate |
| GFR | Usually preserved initially | Often reduced |
Sources: Harrison's Principles of Internal Medicine, 21st Edition, pp. 8392, 8394
Explain everything on nephrotic syndrome and differential diagnosis and difference between nephrotic and nephritic syndrome
search_medical_text
nephrotic syndrome pathophysiology mechanisms proteinuria hypoalbuminemia edema hyperlipidemia
Harrison's Principles of Internal Medicine, Twenty First Edition
Page 1376
search_medical_text
nephrotic syndrome differential diagnosis minimal change disease FSGS membranous nephropathy
Harrison's Principles of Internal Medicine, Twenty First Edition
Page 8394
GradeResponse
GradeResponse
search_medical_text
nephritic syndrome glomerulonephritis hematuria RBC casts hypertension oliguria
search_medical_text
minimal change disease focal segmental glomerulosclerosis membranous nephropathy treatment prognosis
Here is a comprehensive breakdown of nephrotic syndrome, its differential diagnosis, and its distinction from nephritic syndrome.
Nephrotic Syndrome — Complete Overview
1. Definition
Nephrotic syndrome is defined by the triad of:
- Proteinuria > 3.5 g/day (nephrotic-range)
- Hypoalbuminemia < 3.5 g/dL
- Edema (peripheral, periorbital)
Associated features: hyperlipidemia, lipiduria, hypercoagulability.
2. Pathophysiology
(Harrison's, p. 1376)
The central defect is loss of integrity of the glomerular filtration barrier, leading to a cascade of consequences:
A. Glomerular Filtration Barrier Disruption
The normal barrier consists of:
- Fenestrated endothelium — size selectivity
- Glomerular basement membrane (GBM) — charge and size barrier
- Podocytes (visceral epithelial cells) with foot processes — critical charge barrier (anionic coating via podocalyxin)
Injury to podocytes → foot process effacement → loss of charge selectivity → massive protein leak (predominantly albumin).
B. Hypoalbuminemia
- Urinary losses of albumin exceed hepatic synthetic capacity
- Increased proximal tubular catabolism of filtered albumin
- Hepatic synthesis is upregulated but insufficient to compensate
C. Edema Formation (Two Mechanisms)
| Mechanism | Description |
|---|---|
| Underfill hypothesis | ↓ Oncotic pressure → fluid shifts to interstitium → ↓ effective circulating volume → RAAS activation, ADH release, SNS activation → Na+ and water retention → edema |
| Overfill hypothesis | Primary renal Na+ retention (independent of oncotic changes) → volume expansion → edema |
Both mechanisms likely operate, with filtered proteases directly activating ENaC (epithelial sodium channels) in principal cells, perpetuating Na+ retention.
D. Hyperlipidemia
- ↓ Oncotic pressure → hepatic upregulation of lipoprotein synthesis (LDL, VLDL)
- ↓ Lipoprotein lipase activity → impaired clearance
- Result: ↑ total cholesterol, ↑ LDL, ↑ triglycerides, ↓ HDL
E. Lipiduria
- Lipoproteins filtered into urine → taken up by tubular cells → sloughed as oval fat bodies
- Oval fat bodies contain cholesterol crystals visible as Maltese crosses under polarized light
- Appear as fatty casts on urinalysis
F. Hypercoagulability
Urinary loss of anticoagulant proteins:
- ↓ Antithrombin III
- ↓ Protein C and Protein S
- ↓ Plasminogen
- ↑ Fibrinogen (hepatic overproduction)
- Platelet hyperaggregability
→ Risk of deep vein thrombosis, pulmonary embolism, and renal vein thrombosis (especially in membranous nephropathy)
G. Susceptibility to Infection
- Loss of immunoglobulins (IgG) and complement factors (especially Factor B) in urine
- Impaired opsonization → susceptibility to encapsulated organisms (Streptococcus pneumoniae, Haemophilus influenzae)
- Spontaneous bacterial peritonitis is a feared complication, especially in children
3. Clinical Features
| Feature | Details |
|---|---|
| Edema | Bilateral, dependent, pitting; periorbital (especially in children, worse in morning); ascites, pleural effusion in severe cases |
| Frothy/foamy urine | Due to proteinuria |
| Weight gain | Fluid retention |
| Anorexia, malaise | Due to hypoalbuminemia |
| Xanthomas | In chronic hyperlipidemia |
| Thromboembolism signs | Leg swelling, pleuritic chest pain, flank pain (renal vein thrombosis) |
| Infections | Recurrent, especially peritonitis |
| Hypertension | Uncommon in primary NS; more common in secondary causes |
4. Investigations
Urine
| Test | Findings |
|---|---|
| Dipstick | 3+ to 4+ protein |
| 24-hour urine protein | > 3.5 g/day |
| Spot urine PCR | > 3.5 mg/mg (protein:creatinine ratio) |
| Microscopy | Oval fat bodies, Maltese crosses, fatty casts, no/few RBC casts |
Blood
| Test | Findings |
|---|---|
| Serum albumin | < 3.5 g/dL |
| Lipid panel | ↑ Cholesterol, ↑ LDL, ↑ triglycerides |
| BMP/CMP | Creatinine, BUN, eGFR (often normal initially) |
| Complement C3/C4 | Low in MPGN, lupus nephritis; normal in MCD, MN, FSGS |
| ANA, anti-dsDNA | Lupus nephritis |
| Anti-PLA₂R | Positive in ~70% of primary membranous nephropathy |
| SPEP/UPEP | Amyloidosis, multiple myeloma |
| HBsAg, HCV Ab, HIV | Secondary causes |
| Coagulation studies | PT, aPTT, fibrinogen, antithrombin III |
Imaging
- Renal ultrasound: kidney size, echogenicity (enlarged/echogenic in acute NS)
- Doppler: renal vein thrombosis if suspected
Renal Biopsy
- Mandatory in adults to define the underlying glomerulopathy
- Deferred in children (age 1–8) with presumed MCD → empiric steroid trial first; biopsy if steroid-resistant
5. Causes and Differential Diagnosis
(Harrison's, p. 8394)
Primary (Idiopathic) Causes
| Disease | Key Features | Population | Biopsy Findings |
|---|---|---|---|
| Minimal Change Disease (MCD) | Abrupt onset, selective proteinuria (albumin only), responds to steroids, normal light microscopy | Children (most common), young adults | LM: normal; EM: diffuse foot process effacement; IF: negative |
| Focal Segmental Glomerulosclerosis (FSGS) | Non-selective proteinuria, hypertension, hematuria possible, steroid-resistant forms | Adolescents, young adults, Black patients, HIV, obesity | LM: focal (<50% glomeruli) and segmental sclerosis; EM: foot process effacement; IF: IgM, C3 in sclerotic areas |
| Membranous Nephropathy (MN) | Most common in white adults, insidious onset, high thrombosis risk, anti-PLA₂R+ in 70% | Adults >40, male predominance | LM: GBM thickening, "spike and dome" pattern; EM: subepithelial deposits; IF: granular IgG, C3 |
| Membranoproliferative GN (MPGN) | Mixed nephrotic/nephritic, low complement, can follow infections | Children, young adults | LM: mesangial proliferation, GBM double contour ("tram-track"); IF: C3, IgG; EM: subendothelial deposits |
| C3 Glomerulopathy / Dense Deposit Disease | Complement dysregulation, low C3 | Children | EM: dense intramembranous deposits; IF: C3 dominant |
Secondary Causes
| Cause | Associated Disease | Notes |
|---|---|---|
| Diabetic nephropathy | Diabetes mellitus | Most common cause of NS worldwide; Kimmelstiel-Wilson nodules on biopsy |
| Lupus nephritis (Class V) | SLE | Membranous pattern; ANA, anti-dsDNA positive; low C3/C4 |
| Amyloidosis | AL (multiple myeloma), AA (chronic inflammation: RA, FMF, TB) | Congo red stain → apple-green birefringence; SPEP/UPEP |
| Viral infections | HBV (MN), HCV (MPGN), HIV (collapsing FSGS) | Screen all adults |
| Parasitic infections | Malaria (Plasmodium malariae → MPGN) | Tropical regions |
| Drugs | NSAIDs (MCD/MN), gold, penicillamine, captopril, heroin (FSGS) | Drug history essential |
| Malignancy | Solid tumors → MN; lymphoma (Hodgkin's) → MCD | Paraneoplastic; age >60 |
| Pre-eclampsia | Pregnancy | New-onset proteinuria + hypertension after 20 weeks |
| Hereditary | Alport syndrome, Congenital NS (Finnish type, NPHS1 mutation) | Family history, onset in infancy |
6. Complications
| Complication | Mechanism |
|---|---|
| Thromboembolism | Loss of antithrombin III, proteins C and S; renal vein thrombosis (especially MN) |
| Infections | Loss of IgG, complement; SBP, cellulitis, pneumococcal infections |
| AKI | Volume depletion, NSAID use, renal vein thrombosis, interstitial edema |
| Protein malnutrition | Chronic albumin loss |
| CKD progression | Especially FSGS, MN |
| Cardiovascular disease | Accelerated atherosclerosis from hyperlipidemia |
| Vitamin D deficiency | Loss of vitamin D-binding protein → hypocalcemia, bone disease |
| Hypothyroidism | Loss of thyroid-binding globulin (TBG) → low total T4 (free T4 normal) |
7. Management
General Measures
- Low-sodium diet (< 2 g/day) — reduces edema
- Fluid restriction — if severe edema/hyponatremia
- Moderate protein intake — 0.8–1 g/kg/day (high protein worsens proteinuria)
- Statin therapy — for hyperlipidemia (cardiovascular risk reduction)
- Anticoagulation — if serum albumin < 2 g/dL, or active thrombosis (especially in MN)
- Pneumococcal vaccination — due to infection risk
Diuretics (Edema)
- Loop diuretics (furosemide) — first-line; may need IV due to gut edema impairing oral absorption
- Add thiazide or spironolactone for resistant edema
- Albumin infusion + furosemide for refractory cases
RAAS Blockade (Antiproteinuric)
- ACE inhibitors or ARBs — reduce intraglomerular pressure and proteinuria regardless of BP
Disease-Specific Treatment
| Disease | Treatment |
|---|---|
| MCD | Corticosteroids (prednisone) — >90% remission; relapse common; cyclophosphamide/calcineurin inhibitors for frequent relapsers |
| FSGS | High-dose steroids; calcineurin inhibitors (tacrolimus, cyclosporine) for steroid-resistant; sparsentan (novel dual AT1/endothelin receptor antagonist) |
| Membranous Nephropathy | Rituximab (anti-CD20, targets B cells producing anti-PLA₂R) — now first-line for immunotherapy; cyclosporine; cyclophosphamide + steroids (Ponticelli regimen) |
| Lupus Nephritis Class V | Hydroxychloroquine + RAAS blockade; immunosuppression for concurrent proliferative lesions |
| Diabetic Nephropathy | Strict glycemic control, RAAS blockade, SGLT2 inhibitors (empagliflozin, dapagliflozin) — reduce proteinuria and slow progression |
Nephrotic vs. Nephritic Syndrome — Key Differences
These two syndromes represent fundamentally different types of glomerular injury:
| Feature | Nephrotic Syndrome | Nephritic Syndrome |
|---|---|---|
| Primary defect | Loss of glomerular charge/size selectivity → protein leak | Glomerular inflammation → breach of GBM → blood in urine |
| Proteinuria | Massive: > 3.5 g/day | Mild-moderate: < 3.5 g/day |
| Hematuria | Absent or microscopic | Prominent; RBC casts (pathognomonic) |
| Edema | Severe, generalized (periorbital, ascites, pleural effusion) | Mild-moderate |
| Hypertension | Uncommon in primary NS | Common (Na+ and water retention) |
| Oliguria | Absent unless AKI | Common (↓ GFR) |
| Hypoalbuminemia | Prominent (< 3.5 g/dL) | Mild or absent |
| Hyperlipidemia/lipiduria | Present | Absent |
| GFR/renal function | Initially preserved | Often reduced (azotemia) |
| Urine sediment | Fatty casts, oval fat bodies, Maltese crosses | RBC casts, granular casts, dysmorphic RBCs |
| Complement | Normal (MCD, FSGS, MN) or low (MPGN) | Low in post-streptococcal GN, MPGN, lupus |
| Mechanism | Podocyte injury → permeability defect | Immune complex deposition → inflammation → endocapillary proliferation |
Causes of Nephritic Syndrome (for comparison)
| Disease | Key Features |
|---|---|
| Post-streptococcal GN | Children; 2–3 weeks after strep pharyngitis/skin infection; low C3; granular "starry sky" IF |
| IgA Nephropathy (Berger's) | Most common GN worldwide; hematuria after URI (synpharyngitic); mesangial IgA deposits |
| Lupus Nephritis (Class III/IV) | Proliferative; low C3/C4; "full house" IF pattern (IgG, IgA, IgM, C3, C1q) |
| Anti-GBM Disease (Goodpasture's) | Pulmonary hemorrhage + nephritis; linear IgG on IF; anti-GBM antibodies |
| ANCA-associated Vasculitis | Pauci-immune GN (no/few immune deposits); MPO-ANCA or PR3-ANCA; crescentic GN |
| MPGN | Can present as nephritic or nephrotic or mixed; low C3 |
Mixed Presentations
Some diseases can present with features of both syndromes:
- MPGN — heavy proteinuria + hematuria + low complement
- Lupus nephritis (Class III/IV/V) — especially Class IV (diffuse proliferative) with nephrotic-range proteinuria
- Diabetic nephropathy — usually pure nephrotic, but can have microhematuria
Mnemonic: Nephrotic vs. Nephritic
NephROTic = ROT (protein ROTs away) Protein loss, frothy urine, edema, lipid abnormalities, no blood
NephRITic = RITIS (as in nephRITIS/inflammation) Blood, RBC casts, hypertension, oliguria, ↓ GFR
Sources: Harrison's Principles of Internal Medicine, 21st Edition, pp. 1376, 8392, 8394
This is a shared conversation. Sign in to Orris to start your own chat.